Stock SVA SINOVAC BIOTECH LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Sinovac Biotech Ltd.

Equities

SVA

AGP8696W1045

Delayed Nasdaq
Other stock markets
 02:30:00 23/02/2019 am IST 		5-day change 1st Jan Change
6.47 USD -0.31% Intraday chart for Sinovac Biotech Ltd. -.--% -.--%
18/01 Alternative Liquidity Index LP, a fund managed by Alternative Liquidity Capital cancelled the acquisition of 10.04% stake in Sinovac Biotech Ltd. CI
2023 Scientists see risk of lost opportunity for long COVID research in China RE

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Sinovac - WHO releases 2024-2025 Northern Hemisphere influenza vaccine component recommendations, changes to H3N2 virus
AQ
Sinovac Amends Shareholder Rights Plan
BU
Beijing Sinovac Zhongwei Biotechnology Co., Ltd.'s 2024 information disclosure on environmental pollution prevention and control by hazardous wastes
AQ
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
BU
Alternative Liquidity Index LP, a fund managed by Alternative Liquidity Capital cancelled the acquisition of 10.04% stake in Sinovac Biotech Ltd.
CI
Alternative Liquidity Capital Announces Offer to Purchase Common Shares in Sinovac Biotech Ltd.
AQ
Scientists see risk of lost opportunity for long COVID research in China
RE
Sinovac - Study shows, Children aged 3-8 years old receive 2 doses of influenza vaccine for better protection
AQ
Sinovac Biotech Ltd - A delegation from the Indonesian Ministry of Health visited Sinovac
AQ
Sinovac - Sharing and co-building China Sinovac has supplied more than 1.2 billion doses of vaccines to 62 'Belt and Road' countries
AQ
Sinovac Biotech : Clinical trials will advance treatment of COVID-19 infection - Form 6-K
PU
SINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection
BU
Sinovac Biotech Ltd. Reports on the Clinical Trial Progress of Its Anti-Covid-19 Antibody Sa55 Injection
CI
The first study on the protective effect of influenza vaccine for Chinese military personnel shows that Sinovac influenza vaccine has good immunogenicity and safety among military personnel
AQ
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
BU
Sinovac Holdings Biotechnology Co., Ltd. - Announcement on Industrial and Commercial Change of Beijing Kexing Biological Products Co., Ltd.
AQ
Sinovac Confirms Receipt of an Unsolicited Partial Tender Offer
BU
Sinovac Announces Change of Legal Representative of Sinovac Beijing
BU
Alternative Liquidity Index LP, a fund managed by Alternative Liquidity Capital made an offer to acquire 10.04% stake in Sinovac Biotech Ltd. for an offer per share of $0.03.
CI
Sinovac Biotech Ltd. - The second information disclosure of the environmental impact assessment of the Vaccine Quality Research Center project
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SVA Stock
  4. News Sinovac Biotech Ltd.